If this message is not displayed correctly, please click here.

What´s up at IZB 

Dear Mister/Miss Titel ,

there is a fireworks display of exciting news at the IZB right now. In many companies we welcome new managers with excellent industry experience to continue to sustainably implement the visions of the start-ups. In addition, we congratulate Secarna, Thermosome and Bicoll on their research results and funding. 

It is a special pleasure to congratulate Prof. Patrick Cramer, former Director of the Gene Center at the Campus, on his new position as President of the Max Planck Society. We are very much looking forward to welcoming him to the site at the next opportunity. 

Networking is a top priority at the IZB. This is evident from the many events taking place this summer and next fall. Take the opportunity to exchange ideas with the multipliers at the IZB. At the Munich Life Science Pitch Day (July 13, 2023), 16 project teams will present their research this time. We are happy to welcome more than 40 investors this time - and more are welcome!

Enjoy reading the many news from the IZB.

With best regards


Dr. Peter Hanns Zobel
Managing Director IZB

IZB News

Video of the IZBrunch in June

Video IZBrunch June 29, 23

Many thanks to the speakers:

Prof. Dr. Karl Duderstadt, MPI
Research Group "Structure and Dynamics of Molecular Machines". Dynamics of DNA replication, structural biology, single molecule imaging, biophysics.

Jens Klein, Founder & CEO Insempra GmbH.
Topic: How Insempra combines life science and technology to make matter for new, better and more sustainable products on an industrial scale

Malignant cancer cells under microscope


New preclinical data show long-term antitumor effects of Secarna Pharmaceuticals’ antisense oligonucleotide (ASO) therapies

The findings from in vivo and in vitro studies were published in the peer-reviewed Journal for ImmunoTherapy of Cancer (JITC).
Japanese delegation at the IZB

Spotlight: IZB

Japanese delegation at the IZB

Yosei Ide, State Minister of Education, Culture, Sports, Science and Technology in Tokyo, Japan, besuchte den renommierten Life Science Standort in Martinsried bei München.
Rainer Gebhart, Branch Manager at ChromoTek


ChromoTek welcomes Rainer Gebhart as new site manager

In this position, he will manage the research and manufacturing site as well as the commercial aspects of the company.
Rainer Gebhart, Branch Manager at ChromoTek

Networking-Event with Platform Life Sciences

In a relaxed atmosphere, the guests exchanged views on developments in the industry

Dr. Peter Hanns Zobel,  Dr. Manuel Bauer, PhD Niels Sharmann, Benedikt Mahr, Dr. Joachim Greuel and Börge Seeger illuminated the biotech scene.
Moderation: Karin Hofelich and Urs Moesenfechtel
Prof. Hendrik Liebers, Chairman Origenis


Biotech company Origenis welcomes Prof. Hendrik Liebers as Chairman of the Board

The industry expert will play a key role in supporting the company’s strategic development.
Thermosensitive liposomes loaded with active substances.


Thermosome joins IMAGIO consortium to advance development of cancer therapies for soft tissue sarcoma

The company will receive EUR 1.3 million in funding and collaborate with Cologne University Hospital to test its lead drug candidate THE001 in combination with a novel technology.
Konstantin Petropoulos, PhD, MBA, Chief Business Officer


Secarna appoints new Chief Business Officer

Dr. Konstantin Petropoulos will be responsible for expanding Secarna’s industry partnering business and securing the financial base for the Company’s aggressive growth plans.
Bicoll at the BIO International Convention June 2023

Spotlight: Bicoll

Bicoll showcases at BIO International Convention

The start-up continues to advance projects in neuroscience/epilepsy and dermatology.
Midsommar party at the IZB

Spotlight: KLIFO

Midsommar party at the IZB

On June 15, 2023, the IZB startups celebrated a Scandinavian-Bavarian party and invited the startups and surrounding companies to celebrate. Many thanks to Dr. Anthony Harris and Sophie Markert for this nice action!
Titel BioM Report – Biotech in Bavaria


Bavarian biotechnology maintains its position in the crisis and continues to grow

BioM publishes Bavarian Biotech Report 2022/23

EVENT announcement

Life Science Pitch Day at the IZB

Life Science Pitch Day:

July 13, 2023

Investors welcome!

16 project teams will present their great research to over 40 leading life science investors and decision makers in pharma and VC companies. We look forward to welcoming more investors to participate in this extremely exciting event.

The annual business reception will be held on September 21, 2023


Postponed to 21 September 2023

Invitation by Kerstin Schreyer, MdL, Chairwoman of the Economic Committee and Dr. Peter Hanns Zobel, Managing Director IZB.

Keynote: Dr. Theo Waigel, former Federal Minister - "Politics in unsteady times".

Start: 7.00 p.m. - End open



At the Max Planck Society’s Annual General Meeting in Göttingen on 22 June 2023, President Prof. Dr. Martin Stratmann symbolically passed on the responsibility to his successor Prof. Dr. Patrick Cramer by handing over the chain of office.


Official handover ceremony at the Annual Meeting of the Max Planck Society

President Prof. Dr. Martin Stratmann handed over the chain of office to his successor Prof. Dr. Patrick Cramer in front of more than 800 participants..
RESI enables microscopy across length scales at Ångström resolution: From whole cells over individual proteins down to the distance between two adjacent bases in DNA.


Breakthrough in fluorescence microscopy at the Max Planck Institute of Biochemistry

The research team developed a revolutionary technique that enhances the resolution of fluorescence microscopy down to the Ångström scale..


Wanted: Scale-Up & Process Development Manager for Recombinant Peptide & Protein Production (m/f/n)

Job offer:

Scale-Up & Process Development Manager for Recombinant Peptide Protein Production (m/f/d)

Fördergesellschaft IZB mbH


Susanne Simon
Leitung Presse- und Öffentlichkeitsarbeit
Tel.: 089/55 279 48-17
E-Mail: izb@izb-online.de

Standort Martinsried:

Fördergesellschaft IZB mbH
Am Klopferspitz 19
82152 Planegg/Martinsried

Standort Weihenstephan:

Fördergesellschaft IZB mbH
Lise-Meitner-Straße 30
85354 Freising/Weihenstephan

IZB Logo blau